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Abstract

Heparan sulfate proteoglycans modified by human glucosaminyl 3-O-sulfotransferase-3 (3-OST-3) isoform
generates the cellular receptor for herpes simplex virus type 1 (HSV-1). Interestingly, the ability of zebrafish (ZF)encoded 3-OST-3 isoform to modify heparan sulfate to mediate HSV-1 entry and cell–cell fusion has not been
determined although it is predominantly expressed in ZF, a popular model organism to study viral infections.
Here, we demonstrate that expression of ZF-encoded 3-OST-3 isoform renders the resistant Chinese hamster
ovary (CHO-K1) cells to become susceptible for HSV-1 entry. The following lines of evidence support the
important role of ZF-encoded 3-OST-3 isoform as the mediator of HSV-1 entry into CHO-K1 cells: (1) ZF 3-OST3–expressing CHO-K1 cells were able to preferentially bind HSV-1 glycoprotein D, and (2) CHO-K1 cells expressing ZF-encoded 3-OST-3 acquire the ability to fuse with cells expressing HSV-1 glycoproteins. Finally,
knocking down 3-OST-3 receptor by siRNA in ZF fibroblasts cells significantly reduced HSV-1 entry and
glycoprotein D binding to cells. Taken together, our results provide novel insight into the significance of ZF
3-OST-3 isoform as an HSV-1 entry and fusion receptor and its potential involvement in the HSV-1 disease
model of ZF.

Introduction

H

eparan sulfate (HS) is a glycosaminoglycan of
repeating disaccharide units that consist of Nacetylglucosamine and glucuronic=iduoronic acid. During
the biosynthesis of HS, a long chain containing the alternate
disaccharides is modified in a complex series of steps involving N-deactylation=N-sulfation of the glucosamine unit,
C5 epimerization of the glucuronic acid to iduronic acid, and
O-sulfation of both residues by multiple enzymes. The last
O-sulfation step involves 3-O-sulfotransferases (3-OSTs),
which exist in multiple isoforms.1–3 In each of these modification steps, only part of the substrate is modified, resulting in
a high sequence diversity that is thought to give HS proteoglycans (HS proteoglycans) their functional specificity and
versatility.4 Thus, each 3-OST can potentially generate unique
protein-binding sites within the HS chain.5,6 HS moieties
prominently exposed on the cell surface have also been implicated as a primary receptor for human herpesviruses and
many other viruses.5–8

In the case of herpes simplex virus type 1 (HSV-1), it was
first shown that the HS chains can serve as an initial attachment
site or binding receptor for the virions.9 Later, Shukla et al.
suggested that modification of HS by 3-O-sulfotransferase-3
(3-OST-3) generates a unique entry receptor for HSV-1.6 It was
further demonstrated that 3-O sulfated HS (3-OS HS) generated by multiple 3-OSTs can be an important receptor during
cell fusion induced by HSV-1.10–14 Enzymes that modify HS
proteoglycans play essential roles during zebrafish (ZF) embryo development.15–18 Recently, a combinatorial expression
pattern of 3-OST gene family was shown in the ZF model.19 In
addition, adult ZF was presented as a new model system for
HSV-1 infection of the nervous system.20 This study aims to
identify a role for the ZF-encoded 3-OST-3 isoform in HSV-1
entry and spread. The results presented below demonstrate
that the resistant CHO-K1 cells expressing ZF 3-OST-3 isoform
together with ZF fibroblast cells expressing endogenous 3OST-3 receptors are susceptible to HSV-1 entry and spread.
The significance of the functional 3-OST-3 receptor for HSV-1
in ZF will likely develop a new area of investigations
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pertaining to targeted gene disruption, structure–function
analysis of the 3-OSTs gene, and screening for 3-OST-3 inhibitors targeted to block viral entry in the ZF model.
Materials and Methods
Plasmid
ZF-encoded 3-OST-3 gene (1203 bp) was cloned into
pDream2.1 plasmid. Positive clones were selected by PCR and
further verified by DNA sequencing (Genscript). Human
3-OST-3 (H 3-OST-3)–expressing plasmid (pDS43) was a
generous gift from Dr. Shukla (University of Illinois at
Chicago).6 The HSV-1 (KOS)–glycoprotein expressing plasmids used were pPEP98 (gB), pPEP99 (glycoprotein D [gD]),
pPEP100 (gH), and pPEP101 (gL).21 Other plasmids used in
this study include nectin-1 (pBG38), pCAGT7 (T7 RNA
polymerase), and pT7EMCLuc (luciferase gene).
Cell culture and viruses
Wild-type CHO-K1 cells were kindly provided by P.G.
Spear (Northwestern University, Chicago). All CHO-K1 cells
were grown in Ham’s F-12 medium (Gibco=BRL) supplemented with 10% fetal bovine serum, and penicillin and
streptomycin (Gibco=BRL). African green monkey kidney
(Vero) cells were grown as previously described.22 The bgalactosidase-expressing recombinant HSV-1 (KOS) gL866
and green fluorescent protein (GFP)–expressing HSV-1
(K26GFP) were provided by P.G. Spear (Northwestern University, Chicago) and P. Desai ( Johns Hopkins University).23
ZF fibroblasts cells (ZF4) obtained from American Type Culture Collection were grown in recommended the medium
(DMEM:F12) and culture conditions.
HSV-1 entry assay
The entry assay previously described was used.22 CHOK1 cells were grown in six-well plates to subconfluence
and transfected with 2.5 mg of human or ZF-encoded 3-OST
isoform (3-OST-3), or with pDream2.1 empty vector using
LipofectAMINE (Gibco=BRL). At 16 h posttransfection, the
cells were replated into 96-well dishes for infection with recombinant virus HSV-1 (KOS) gL86 at the plaque-forming
units (pfu) indicated. After 6 h postinfection, b-galactosidase
assays were performed using either a soluble substrate
o-nitrophenyl-b-D-galactopyranoside (at 3.0 mg=mL; ImmunoPure, Pierce) or X-gal (Sigma). For the soluble substrate,
the enzymatic activity was measured at 410 nm using a microplate reader (ELX808 absorbance microplate reader; BioTek
Instruments Inc.).
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capsid, specifically on the tips of the hexons that constitute
the capsid shell. At 90 min postinfection, cells were fixed with
2% formaldehyde and 0.2% glutaraldehyde and stained
with 10 nm rhodamine-conjugated phalloidin (Invitrogen) for
F-actin. Images of immunofluorescent-labeled cells were acquired using a confocal microscope (Nikon D-Eclipse-C1)
with software EZ-C1.
Enzyme-linked immunosorbent assay
As previously described, an enzyme-linked immunosorbent
assay with entire cells and a chimeric form of HSV-1 gD with
rabbit IgG Fc (gD1:Fc) was used.6 Briefly, cells were transfected
with identical amounts of 3-OST-3, or nectin-1-expressing
plasmids. After the monolayers were grown to confluence,
soluble gD1:Fc was added for 1 h. After multiple rounds of
washing, gD1:Fc binding was detected by biotinylated antirabbit IgG (1:5000 in phosphate-buffered saline [PBS] with 3%
bovine serum albumin) (Sigma) and a horseradish peroxidase
detection system (AMDEX streptavidin-conjugated horseradish peroxidase from Amersham) diluted 1:20,000. A slow
kinetic form of 3-, 30-, 5-, 50-tetramethylbenzidine (Sigma) was
used as the substrate. The optical density was read immediately after adding the substrate at 650 nm using a microplate reader (ELX808 absorbance microplate reader; BioTek
Instruments Inc.).
HSV-1 glycoprotein induced cell fusion assays
A cell-to-cell fusion assay described previously was
used.10,24 CHO-K1 cells were grown in six-well plates to subconfluent levels. The so-called target cells were transfected
with plasmids expressing 3-OST-3 isoform and the luciferase
gene. The effector or virus-like cells were cotransfected with
plasmids expressing HSV-1 glycoproteins gB, gD, gH, and gL,
and T7 RNA polymerase. In either case, the total amount of
DNA used for transfection was kept constant. After 16 h, target
and effector cells were mixed in a 1:1 ratio and then replated in
24-well dishes. The activation of the reporter luciferase gene as
a measure of cell fusion was examined after 24 h. Luminosity
readings were obtained using a Sirius luminometer (Berthold
Detection Systems). Cell fusion was observed by microscopy
following Giemsa (Fluka) staining or quantified using a luciferase reporter gene activation assay as previously described.24
Heparinase treatment
ZF4, CHO-K1 expressing human-encoded 3-OST-3 receptor, and HeLa cells were pretreated with heparinase-II and -III
(4 U=mL; Sigma) or with 1PBS alone and incubated for
90 min at room temperature. The cells were then washed with
PBS and used for the viral entry.

Fluorescent microscopy of viral entry
Cultured monolayers of CHO-K1 cells expressing H 3-OST3 and ZF 3-OST-3 (approximately 106 cells=well) were grown
overnight in F-12 media containing 10% fetal bovine serum
on chamber slides (Lab-Tek). Wild-type CHO-K1 cells expressing pDream2.1 served as a negative control. The cells
were infected with GFP-tagged HSV-1 (VP26-GFP) at 25
plaque-forming units (pfu)=cell in serum-free media OptiMEM (Invitrogen). The GFP was fused with the HSV-1 UL35
open-reading frame that encodes a 12-kDa capsid protein
designated VP26.23 VP26 is located on the outer surface of the

Si-RNA interference of ZF-encoded 3-OST-3
SiRNA that downregulate ZF 3-OST-3 RNA expression
(Invitrogen) was tested in ZF fibroblast cells (ZF4) to interfere
with receptor formation. ZF4 cells were plated onto a six-well
tissue culture dish and were transfected with appropriate
RNA duplexes along with control duplex. After 24 h, cells
were loosened with cell dissociation buffer (Invitrogen) and
replated onto 96-well tissue culture dishes. Viral entry assays
were performed as previously described with serial dilutions
of HSV-1 (KOS) gL86.6 As stated earlier, a spectrophotometer
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at an optical density of 410 nm was used to measure bgalactosidase activity.
Results
Wild-type CHO-K1 cells expressing ZF-encoded
3-OST-3 isoform is susceptible to HSV-1 entry
Wild-type CHO-K1 cells are resistant to HSV-1 entry due to
lack of a functional HSV-1 gD receptor and thus provide a
very useful reagent for the discovery of gD receptors.9
Therefore, to determine the ability of ZF-encoded 3-OST-3
isoform to mediate HSV-1 entry, CHO-K1 cells were transiently transfected with the ZF 3-OST-3 expression plasmid.
Entry assays were performed using reporter HSV-1 (KOS)
gL86 virus to determine whether expression of ZF 3-OST-3
leads to viral entry in resistant CHO-K1 cells. In this assay,
we compared the viral entry in CHO-K1 cells expressing ZFencoded 3-OST-3 with that of a human-encoded 3-OST-3
(positive control). CHO-K1 cells expressing an empty vector
pDream2.1 was used as the negative control. As shown
(Fig. 1A), there was a significant increase in viral entry in ZF 3OST-3-expressing cells relative to those cells that were transfected with empty vector alone. For HSV-1 entry, the dosage
response seen with ZF-encoded 3-OST-3-expressing CHO-
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K1 cells were very similar to that of the H 3-OST-3-expressing
cells. This result was further confirmed by X-gal assay. As
shown in Figure 1B, panel a, X-gal (5-bromo-4-chloro-3indolyl-b-D-galactosidase) activity was found to be positive
for H 3-OST-3 cells similar to ZF 3-OST-3 cells (Fig. 1B, panel
b). Wild-type CHO-K1 cells expressing pDream2.1 empty
vector remained resistant to HSV-1 entry (Fig. 1B, panel c).
To generate more direct and visual evidence for viral entry,
we used GFP-tagged capsid of HSV-1 (VP26GFP)22,23 to infect
ZF 3-OST-3-expressing CHO-K1 cells. The image of infected
CHO-K1 cells expressing human- and ZF-encoded 3-OST-3
with HSV-1VP26GFP virus showed maximum green viral
capsid accumulation around the cell membrane and its colocalization with F-actin (red)–stained cells (Fig. 1C, panel b)
similar to CHO-K1 cells expressing H 3-OST-3 receptor (Fig.
1C, panel a), whereas CHO-K1 cells expressing pDream2.1
empty vector showed little viral capsid binding and no colocalization with cell membrane (Fig. 1C, panel c).
CHO-K1 cells expressing ZF 3-OST-3 isoform
preferentially binds to soluble HSV-1 gD
To provide evidence for the generation of gD receptors
within HS by the action of ZF-encoded 3-OST-3 enzyme, a

FIG. 1. Expression of zebrafish (ZF) 3-O-sulfotransferase-3
(3-OST-3) isoform in wild-type Chinese hamster ovary
(CHO-K1) cells results in herpes simplex virus type 1 (HSV1) entry. (A) Dose–response curve of HSV-1 entry into CHOK1 cells expressing ZF 3-OST-3 isoform. Resistant wild-type
CHO-K1 cells were transfected with ZF 3-OST-3 at 2.5 mg
DNA, which in resulted HSV-1 KOS (gL86) entry, similar to
human 3-OST-3 (H 3-OST-3) expression. Cells transfected
with empty vector pDream2.1 at 2.5 mg DNA was used as a
negative control. The enzymatic activity was measured at an
optical density of 410 nm (OD410). Each value shown is the
mean of three or more determinations (standard deviation). (B) HSV-1 entry into ZF 3-OST-3 isoform expressing
CHO-K1 cells was confirmed by X-gal staining. CHO-K1 cells
(4106 cells) expressing H 3-OST-3 (panel a) and ZF 3-OST-3
(panel b) were challenged with b-galactosidase-expressing
recombinant HSV-1 KOS (gL86) at 25 pfu=cell. Wild-type
CHO-K1 cells expressing pDream2.1 (panel c) were also infected in parallel as a negative control. After 6 h of infection
at 378C, cells were washed with phosphate-buffered saline,
fixed, permeabilized, and incubated with X-gal (5 bromo-4
chloro-3-indoyl-b-D-galactosidase) at 1.0 mg=mL, which
yields an insoluble blue product upon hydrolysis by bgalactosidase. Blue cells (representing viral entry) were
identified. Microscopy was performed using a 20objective
of Nikon D-Eclipse-C1. (C) Observation of HSV-1 entry in
cultured CHO-K1 expressing ZF 3-OST-3 isoform. Confluent
monolayers of ZF 3OST-3 CHO-K1 cells (panel b) were infected with green fluorescent protein–tagged capsid of HSV1 (VP26-green fluorescent protein) at 25 pfu=cell for 90 min.
In parallel CHO-K1 cells expressing pDream2.1 (panel c) and
H 3-OST-3 (panel a) were used as negative and positive
controls, respectively. At 90 min postinfection, cells were
fixed with 2% formaldehyde and 0.2% glutaraldehyde, and
stained with 10 nm rhodamine-conjugated phalloidin (red)
for F-actin. The images were taken using a fluorescent confocal microscope (Nikon D-Eclipse-C1) at 40 objective.
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previously defined soluble gD-cell binding assay was used.6
This assay is based on the principle that a recombinant soluble
form of HSV-1 gD fused with the Fc portion of rabbit IgG
(gD:Fc) can preferentially bind to cells expressing 3-OS HS.
Interestingly, in the case of 3-OS HS, but not for nectin-1, the
preferential binding of gD to cells can be reversed by prior
treatment of cells with heparin lyases (heparinases).6 Thus,
CHO-K1 cells were transiently transfected with ZF and H
3-OST-3 isoforms, or nectin-1, and each divided into two
groups. While one group was treated with a mixture of heparinase-II and -III, the other was mock treated with the buffer
alone for the same amount of time. As shown in Figure 2, there
was a significantly higher amount of gD:Fc bound to the
mock-treated 3-OST-3-expressing cells than those cells that
were treated with heparinase-II and -III. The same pattern,
however, was not seen with nectin-1-expressing cells. Taken
together with the results from the gD-mediated interference
assay, it is very likely that expression of ZF 3-OST-3 in CHOK1 cells results in the generation of HSV-1gD receptors.
ZF-encoded 3-OST-3 mediates HSV-1
glycoprotein-induced cell-to-cell fusion
After establishing the ability of 3-OST-3 to serve as a receptor for HSV-1 entry, we next examined whether the same
receptor could also facilitate cell-to-cell fusion. Once again
CHO-K1 cells were used that are also resistant to virusinduced cell fusion due to the absence of a gD receptor.10 A
luciferase reporter gene assay was performed to quantify the
induced cell fusion between 3-OS HS cells modified by 3-OST3 and HSV-1 glycoproteins.10 The effector CHO-K1 cells
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were transiently transfected with each of four glycoprotein
plasmids—pPEP98 (gB), pPEP99 (gD), pPEP100 (gH), and
pPEP101 (gL)—as well as the plasmid pT7EMCLuc that
expresses a luciferase reporter gene. The target cells were
transfected with a 3-OST plasmid expressing ZF-encoded
3-OST-3 and the plasmid pCAGT7, which expresses T7
RNA polymerase to induce expression of the luciferase gene.
For a negative control, cells were transfected with T7 RNA
polymerase and 3-OST-1 because 3-OS HS modified by this
isoform has been shown not to interact with HSV-1.10 The
cells expressing H 3-OST-3 and T7RNA polymerase served
as a positive control. Figure 3A shows a high amount of
fusion occurring in both human- and ZF-encoded 3-OST-3expressing cells. Next to verify the results obtained by the
luciferase assay, we looked at polykaryocyte formation by
mixing ZF-encoded 3-OST-3 expressing target cells with the
effector cells. This phenomenon mimics multinucleated cell
(polykaryocyte) formation during an in vivo HSV-1 infection
when infected cells fuse with uninfected cells, allowing the
spread of the virions to the neighboring cells. Our results
show that the polykaryocytes of similar number (Fig. 3B) and
sizes were formed in both the cell populations expressing
H 3-OST-3 (Fig. 3C, panel b) and ZF 3-OST-3 (Fig. 3C, panel c).
Virtually no polykaryocytes were seen in the negative control
3-OST-1-expressing cells (Fig. 3C, panel a). These results reinforce our finding that cells expressing ZF 3-OST-3 allow cell
fusion to occur, and thus potentially could facilitate spread of
HSV-1 in an in vivo infection.
3-OST-3 is required for HSV-1 entry into ZF fibroblast
We next verified the significance of ZF-encoded 3-OST-3
entry receptor for HSV-1 entry in ZF fibroblast (ZF4) cells. The
cells were pretreated with heparinase enzyme to remove both
HS and 3-OST-3 receptor from the cell surface. Less viral entry
was observed for cells when heparinase (Fig. 4A) had been
used in both ZF4 and CHO-K1 cells expressing H 3-OST-3
receptor; however, HeLa cells that use nectin-1 as the gD receptor showed no decrease in entry (Fig. 4A), suggesting that
ZF-encoded 3-OST-3 receptor plays a significant role in the
entry process.
ZF-encoded 3-OST-3 acts a major receptor
for HSV-1 entry into ZF fibroblast

FIG. 2. Enzymatic removal of 3-OST-3-modified heparan
sulfate from cells removes glycoprotein D (gD)–binding receptors. A soluble recombinant form of HSV-1 gD (gD:Fc)
was allowed to bind cells expressing the 3-OST isoforms (ZF
3-OST-3 and H 3-OST-3) and the cells expressing nectin-1 as
indicated. The cells were either treated with a mixture of
heparinase-II=-III (treated at 4 U=mL) or mock treated (untreated). Binding of gD:Fc was detected by use of a secondary antibody against rabbit IgG:Fc and a horseradish
peroxidase detection system. The values shown represent the
amount of reaction product detected spectrophotometrically
(OD650). The data shown are the means of triplicate measures
and are representative of three independent experiments.
Double asterisks indicate significant difference from other
treatments ( p < 0.01, t-test); error bars represent SD.

To prove that 3-OST-3 receptor is critical for HSV-1 entry in
ZF fibroblast; 3-OST-3 receptor was downregulated using
siRNA against ZF 3-OST-3 in ZF fibroblast cells. Significantly
less viral entry (Fig. 4B) and gD binding to cells (Fig. 4C) was
observed when 3-OST-3 was downregulated by siRNA compared to scramble siRNA, suggesting that the 3-OST-3 may be
major mediator of HSV-1 entry into ZF fibroblasts.
Discussion
Our previous studies demonstrated that H (human) 3-OST3-modified HS serves as a receptor for HSV-1 entry in primary
cultures of human corneal fibroblasts and viral-glycoproteininduced cell fusion.22,24 Because more than 70% sequence
similarities were identified between ZF-encoded 3-OST-3 and
H 3-OST-3 gene,19 but not with other isoforms of 3-OSTs, it
appeared logical to test ZF HS modified by 3-OST-3 isoform
for their ability to mediate entry and fusion for HSV-1. The
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FIG. 3. (A) ZF 3-OST-3-expressing target CHO-K1 cells gain the ability to fuse with effector cells coexpressing HSV-1
glycoproteins gB, gD, gH, and gL. The target cells were transfected with plasmids expressing H 3-OST-3 and ZF 3-OST-3 (as
indicated), and luciferase reporter gene. The effector cells were transfected with HSV-1 glycoproteins gB, gD, gH, and gL, and
T7 RNA polymerase. A luciferase reporter assay was performed 24 h after the two cell populations were mixed together. Cell
fusion was measured in relative luciferase units (RLUs) using a Sirius luminometer (Berthold Detection System). (A) Expression of ZF 3-OST-3 isoform results in the fusion of CHO-K1 cells with HSV-1-glycoprotein-expressing cells as measured
by a luciferase assay system with reporter lysis buffer (Promega). The data shown are the means of triplicate measures and
are representative of three independent experiments. Double asterisks indicate significant difference from other treatments
( p < 0.01, t-test); error bars represent SD. (B) Quantitative determination of the number of fused polykaryocytes formed after
coculture of target cells expressing either ZF-encoded 3-OST-3 or human-encoded 3-OST-3 receptors with the effector CHOK1 cells expressing HSV-1 glycoproteins. Target CHO-K1 cells expressing empty vector (pDream2.1) cultured with effector
CHO-K1 cells were used as negative controls. The data shown are the means of triplicate measures with three independent
experiments. Double asterisks indicate significant difference from other treatments ( p < 0.01, t-test); error bars represent SD.
(C) Multinucleated cells or polykaryocytes were microscopically observed with cells expressing H 3-OST-3 (panel b) and=or
ZF 3-OST-3 (panel c), but not with cells expressing control vector pDream2.1 (panel a). CHO-K1 target cells transfected with
plasmids expressing H 3-OST-3 or ZF 3-OST-3 were mixed with the HSV-1 glycoprotein expressing effector cells, and stained
with Giemsa at 24 h postmixing. The effects of H 3-OST-3- or ZF 3-OST-3-expressing CHO-K1 cells on multinucleated
polykaryocytes formation were observed. Shown are photographs of representative cells (Nikon) after 24 h.

novel finding presented herein is that 3-OS HS generated by
ZF-encoded 3-OST-3 isoform can also mediate HSV-1 entry
and cell-to-cell fusion by polykaryocyte formation in CHOK1 cells that lack endogenous 3-O-sulfation.6 The significance
of ZF-encoded 3-OST-3 receptor was further demonstrated in
ZF fibroblast cells, where downregulation of 3-OST-3 receptors significantly reduced the HSV-1 entry (Fig. 4B). These
results suggest the possible involvement of 3-OST-3 receptor
in the embryo or adult fish model of HSV-1 infection.
The knowledge that ZF 3-OS HS modified by 3-OST-3 is the
mediator for polykaryocyte formation in cell culture can be
useful for following reasons: (1) it can lead the way for the
development of anti-3-OS HS compounds that can potentially

block 3-OS HS in the spread of infection in ZF models, (2) 3OST-3 and other 3-OST isoforms knockouts in ZF can be tested for HSV-1 infection, (3) because the 3-OST-3 gene family is
differentially regulated in ZF,19 it is possible that we might
generate a HSV-1 tropism model in animals and understand
viral pathogenesis in more detail in terms of spread or the
establishment of latency, and (4) a model animal for herpes
stromal keratitis can be also established in ZF cornea, which in
turn is similar to human cornea by structure and development.25 An important question remains to be demonstrated is
whether ZF-encoded 3-OST-3 alone or other isoforms of ZFencoded 3-OS HS can also mediate the HSV-1 spread or
polykaryocyte formation in the infected model of ZF. There is
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growing literature on the use of ZF to model viral disease
including HSV-1.20,26–30 While the study of disease processes
in the ZF is a powerful tool in its own right, the development
of ZF models of viral entry and spread is also a first step for
their use in antiviral drug discovery, especially for anti-3OS
HS compounds targeted against HSV. ZF’s competitive advantage over other model systems is optical clarity in a vertebrate embryo amenable to large-scale screening, including
genetic and small molecule drug screens.
In summary, our work attempts to appreciate the potential
contribution of ZF-encoded 3-OST-3 as a receptor for HSV-1.
One recent study indicated that ZF is an excellent experimental organism to study the biological roles of glycosaminoglycans because of the difference in the disaccharide and
sulfation pattern that exists among ZF of different stages of
embryonic development.31 In this context the differential
pattern of ZF 3-OST-3 expression may become even more
interesting to test if the 3OS HS variability reflects in any
change in HSV-1 pathogenesis or cell tropism. Our study is
likely to advance ZF as an alternate model system to study
unique interactions between HSV-1 gD and modified forms
of HS.
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FIG. 4. (A) Effect of heparinase treatment on HSV-1 entry
into ZF fibroblast (ZF4) cells. Cultured ZF4, control CHOK1 cells expressing H 3-OST-3 receptor and HeLa cells were
treated with heparinase-II and -III (4 U=mL) in 96-well tissue
culture dishes. A separate set of cultured cells were mock
treated with phosphate-buffered saline alone. The cells were
then exposed to HSV-1 (KOS) gL86 at 25 pfu=cell, and viral
entry was quantitated 6 h later by o-nitrophenyl-b-Dgalactopyranoside assay. Data shown are the means of
triplicate measures. (B). siRNA downregulation of 3-OST-3
receptor significantly affects HSV-1 entry in ZF4 cells. HSV-1
entry was determined in ZF4 cells transfected with ZFencoded 3-OST-3-specific siRNA. Cells transfected with an
equal amount of scrambled siRNA were used as control. The
cells were then exposed to HSV-1 (KOS) gL86 at 25 pfu=cell,
and viral entry was quantitated 6 h later by o-nitrophenyl-bD-galactopyranoside assay. Data shown are the means of
triplicate measures. (C) HSV-1 glycoprotein D (gD) binding
to ZF4 cells is significantly affected by siRNA downregulation of 3-OST-3 receptor. A soluble recombinant form
of HSV-1 gD (gD:Fc) was allowed to bind ZF4 cells transfected with control siRNA (black bar) and 3-OST-3-specific
siRNA (white bar). Binding of gD:Fc was detected by use of a
secondary antibody against rabbit IgG:Fc and a horseradish
peroxidase detection system. The values shown represent the
amount of reaction product detected spectrophotometrically
(OD650). The data shown are the means of triplicate measures
and are representative of three independent experiments.
Double asterisks indicate significant difference from other
treatments ( p < 0.01, t-test); error bars represent SD.
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